AXS26 Asembia Specialty Pharmacy Summit: Leading the Evolution of Specialized Care [Los Angeles Times (CA)]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Los Angeles Times
The number of available specialty medications has grown from roughly 30 in the mid-1990s to 500 today. Modern specialty medications currently treat over 7,000 different disease states. Artificial intelligence and consumer applications are reducing prescription fulfillment times from several days to minutes. The upcoming AXS26 Summit will feature a shift toward personal narrative by including cultural icon Charlie Sheen to discuss resilience. The Evolution of Specialty Pharmacy The landscape of medical treatment is undergoing a massive shift toward highly specialized care. The upcoming Asembia AXS26 Specialty Pharmacy Summit , scheduled for April 26-30, 2026, in Las Vegas, will address the complexities of this expanding sector. The conference serves as a central meeting point for healthcare executives, digital health innovators, policy makers , and pharmaceutical manufacturers. Data from the previous year's AXS25 Summit illustrates the sheer scale of this medical transitio
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Wiley (WLY) Q3 2026 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- AI Momentum, Material Margin Expansion, and Cash Flow Growth Highlight Wiley's Third Quarter 2026 [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on IQVIA: “I Like the Business Very Much, I Just Don't Know Whether This Is the Right Stock to Play It” [Yahoo! Finance]Yahoo! Finance
- Is IQVIA (IQV) Offering An Opportunity After Recent Share Price Declines? [Yahoo! Finance]Yahoo! Finance
- Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/5/26 - Beat
IQV
Sec Filings
- 2/27/26 - Form ARS
- 2/27/26 - Form DEFA14A
- 2/27/26 - Form DEF
- IQV's page on the SEC website